PUBLISHER: The Business Research Company | PRODUCT CODE: 1712722
PUBLISHER: The Business Research Company | PRODUCT CODE: 1712722
Minimally invasive surgery devices refer to surgical tools designed for procedures requiring smaller incisions or promoting faster healing. These devices can be implanted inside the patient during surgery.
The primary types of minimally invasive surgery devices include handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, and monitoring and visualization tools. Electrosurgical devices are particularly used for tissue destruction, incision, and controlling bleeding through coagulation. These devices find applications across various medical fields such as laparoscopy, cardiovascular surgery, cosmetic surgery, orthopedics, obstetrics and gynecology, ophthalmology, neurosurgery, urology, and others. They are utilized by end-users including hospitals, ambulatory surgical centers (ASCs), and research institutes.
The minimally invasive surgery devices market research report is one of a series of new reports from The Business Research Company that provides minimally invasive surgery devices market statistics, including minimally invasive surgery devices industry global market size, regional shares, competitors with a minimally invasive surgery devices market share, detailed minimally invasive surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive surgery devices industry. This minimally invasive surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The minimal invasive surgery devices market size has grown strongly in recent years. It will grow from $34.17 billion in 2024 to $36.61 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, growing geriatric population, rising prevalence of obesity, growing demand for natural orifice transluminal endoscopic surgery.
The minimal invasive surgery devices market size is expected to see strong growth in the next few years. It will grow to $46.14 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to global expansion of healthcare, growing trend of patient-centric care, patient demand for less invasive procedures, surgeon training and experience. Major trends in the forecast period include robotics and AI integration, remote surgery and telesurgery, single-incision surgery, natural orifice surgery, 3d printing and custom devices.
The rising awareness of minimally invasive surgeries among the public is fueling the market for minimally invasive surgical devices. These procedures involve smaller incisions in the skin compared to traditional surgical techniques, resulting in less pain, shorter hospital stays, reduced scarring, decreased risk of bleeding and infections, and minimal tissue damage. For example, in August 2023, The Aesthetic Society, a US-based organization specializing in plastic surgery and cosmetic medicine, reported that Americans spent over $11.8 billion on minimally invasive surgical procedures in total, marking a 2% increase from the previous year. Consequently, the growing interest in minimally invasive surgery (MIS) is expected to drive demand in the market for minimally invasive surgical devices.
The increasing prevalence of chronic diseases is anticipated to propel the minimally invasive surgery market in the coming years. Chronic diseases are enduring health conditions that usually last for three months or longer, significantly impacting an individual's quality of life. Factors such as an aging population, unhealthy lifestyle choices, and rising obesity rates contribute to the rise in chronic diseases. Minimally invasive surgery offers safer, less painful treatment options for managing these conditions, resulting in faster recovery times and fewer complications. For example, in February 2024, the World Health Organization, a United Nations agency based in Switzerland, projected that over 35 million new cancer cases will emerge by 2050, representing a 77% increase compared to the estimated 20 million cases in 2022. Thus, the increasing prevalence of chronic diseases is driving growth in the minimally invasive surgery market during the forecast period.
Technologically advanced minimally invasive surgery devices, incorporating improvements in image guidance, fiber-optics, mini dental implants, and robotic control systems, are gaining traction among patients seeking effective medical treatments. These devices, characterized by enhanced capabilities in imaging, micromachining, and robotic systems, are witnessing increased adoption in healthcare. Notably, procedures like video-assisted thoracoscopic surgery (VATS) exemplify the shift towards less invasive techniques, utilizing video cameras and advanced imaging technology for treating lung-related conditions. The burgeoning application of MIS techniques, including single-site laparoscopic surgery, needlescopic surgery, and cardiac and spinal surgeries, among others, underscores the evolving landscape of minimally invasive procedures in healthcare.
Major players within the minimally invasive surgery market are directing their efforts towards innovative product development to bolster their market presence and competitive edge. Notably, the introduction of microrobotic tools, such as the tiny robotic hand developed by University of Toronto researchers in June 2023, represents a significant stride in this domain. Operated via an electromagnetic system, this microrobotic tool functions as a surgeon's hand during minimally invasive brain surgery, enabling access to intricate brain areas with minimal invasiveness. Such innovations promise expedited treatments and recoveries for patients, highlighting the impetus on novel product development within the minimally invasive surgery market.
Food and Drug Administration Act (FDA) regulates the minimally invasive surgical devices market in the United States of America. The firms manufacturing robotic minimally invasive surgical devices have to list down any possible risks to health and measures taken by them so that the device addresses health hazards if any stated by FDA. However, the FDA is concerned about the health care providers and patients for not being aware of the safety and effectiveness of these devices as they should not be used in mastectomy procedures or prevention or treatment of cancer.
Major companies operating in the minimal invasive surgery devices market include Abbott Laboratories, GE Healthcare, Medtronic plc, Siemens Healthineers, Smith & Nephew Plc., Stryker Corporation, Boston Scientific Corporation, EthiconInc., B. Braun Melsungen Ag, Conmed Corporation, Microline SurgicalInc., Zimmer Biomet HoldingsInc., Aesculap Inc., Koninklijke Philips NV, F. Hoffmann-La Roche AG, Cardinal Health inc., Baxter International Inc., Danaher Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, Cook Medical, Intuitive Surgical Inc., Smiths Medical, Teleflex Incorporated, Terumo Corporation, Merit Medical Systems, AngioDynamics, MicroPort Scientific Corporation, Lumenis
North America was the largest region in the minimally invasive surgery devices market in 2024. Western Europe was the second-largest region in the global minimally invasive surgery devices market analysis. The regions covered in the minimal invasive surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the minimal invasive surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The minimally invasive surgery devices market consists of sales of graspers, retractors/elevators, dilators, suturing instruments, laparoscopes, gastroscope, cystoscope, and ureteroscop. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Minimal Invasive Surgery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on minimal invasive surgery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for minimal invasive surgery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The minimal invasive surgery devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.